Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer - Wikidata - wikimedia - TriplyDB

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

http://www.wikidata.org/entity/Q28264424

about

The 'invisible hand': regulation of RHO GTPases by RHOGDIs RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.Up-regulation of RhoGDI2 in human breast cancer and its prognostic implications Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets Cdc42 in oncogenic transformation, invasion, and tumorigenesis Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.Tumor-vascular interactions and tumor dormancy Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α Metastasis suppressor genes at the interface between the environment and tumor cell growth Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity.RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment RhoGDI3 and RhoG: Vesicular trafficking and interactions with the Sec3 Exocyst subunit.Learning therapeutic lessons from metastasis suppressor proteins.Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat.Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.The faces and friends of RhoGDI2.Differential tissue-specific protein markers of vaginal carcinoma.RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.Placenta-specific novel splice variants of Rho GDP dissociation inhibitor β are highly expressed in cancerous cells.Metastasis suppressors and the tumor microenvironment Extracellular superoxide dismutase regulates the expression of small gtpase regulatory proteins GEFs, GAPs, and GDI.RhoGDIβ Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation Positive regulation of Rho GTPase activity by RhoGDIs as a result of their direct interaction with GAPs RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis.Metastasis suppressors and their roles in breast carcinoma.Genetic alterations in urothelial bladder carcinoma: an updated review.The role of metastasis suppressor genes in metastatic dormancy.RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.Centrosomal localization of RhoGDIβ and its relevance to mitotic processes in cancer cells Roles of rho GTPases in intracellular transport and cellular transformation.

P2860

Q24606819-6FA85B73-8B5D-42C1-8990-2CFF715CAB06 Q24608385-4BE83EBB-E179-41E6-AC52-5B5A2B22D30B Q24632730-E3882BF9-52EE-4640-AC45-A83D9DC3B843 Q24645336-ACB69CF8-1FAC-41EB-997B-8EB6277956D6 Q24656469-EE454F56-F8A3-43AB-9C7B-1A76671503A5 Q24658329-8415CA8D-9D61-430D-B109-EF810617B68F Q26782593-B697F324-B544-47DB-919D-8C09539EED53 Q28236231-CBBAB784-48B9-4BC6-B488-1D307CA14B22 Q28291731-177F5915-5975-423C-9A10-ADD2426471F0 Q28295975-D86E4684-1439-4C9A-97FD-97BAB274EA18 Q28308069-FB54C9CE-FF46-47B7-8CD3-7295B8446872 Q28394526-0F85E1EB-3479-4913-86D4-0E446DE206E1 Q30279180-CDB1C93F-0643-433C-BA8E-52E83141E67A Q30301104-AD8280BA-BD80-445E-9CC7-E29CFFBDA0CD Q30415154-ED793725-3246-4C0D-AA7E-288F968AFB01 Q30417613-8032AF59-CB79-4B20-BC15-DCE5C816314A Q30423871-BFFFC303-AEBF-4134-B712-BEBB7CA44DFF Q30431874-AAF4C190-94CA-4F61-81D3-943B3F5A06A4 Q30435922-52B3C641-1CCD-449D-9DC2-F91E4F4A55D6 Q30437629-B49C8414-8045-4A66-8252-C5946E71EFBC Q30439612-5DD14DCC-3599-4D42-A62F-232E5C204F69 Q30441149-B11BDE3C-7408-4A14-AC16-3AEC27C129B2 Q30444715-E042D818-EF43-4DAD-BE94-2E07653D7B4D Q30446429-D8B4B944-DCA2-4552-BA1C-092F6999DE75 Q30455699-95956A1C-1762-4ACE-948F-2B301C15F2C6 Q33430245-CD949575-6C84-43E4-8BB3-6413199696BF Q33688924-DB1FCA84-94D7-4D9D-B040-C99269973AB6 Q34498722-0EF83214-5123-4972-B615-46070D55207D Q34648929-7C3AE403-6C86-4A64-B131-28707225C8D6 Q35159451-4B9773FD-5BA2-41BC-94B5-C1B38B0F415D Q35536339-79FF2EEE-5455-432B-9F07-647059B1D41E Q35550465-7896ADE0-357A-4921-A1E2-B1CAB2877DA4 Q35578252-D2882E3C-D7B7-4D54-89E2-95D061D836A5 Q35981102-B0A6BB84-61B2-4A0F-A22E-E9FD0F90011A Q36393012-FF632C52-DD41-4D56-94A5-EF8CE32DD013 Q36429964-1C9A050B-34A3-4080-985F-8529FD81269B Q36544952-4A82FFC7-6D7E-4F53-A724-1A36A6C79942 Q36616513-808653BA-228A-43C4-B207-85C44AA2C97A Q36643144-059EDDE0-B84A-4EB8-A41C-4FBFF42B1116 Q36820419-FA205D5B-24C7-47DE-A4D9-B6D719000AA4

P2860

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

http://www.wikidata.org/entity/Q28264424

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Reduced expression of metastas ...... r patients with bladder cancer

@ast

Reduced expression of metastas ...... r patients with bladder cancer

@en

Reduced expression of metastas ...... r patients with bladder cancer

@nl

type

label

Reduced expression of metastas ...... r patients with bladder cancer

@ast

Reduced expression of metastas ...... r patients with bladder cancer

@en

Reduced expression of metastas ...... r patients with bladder cancer

@nl

prefLabel

Reduced expression of metastas ...... r patients with bladder cancer

@ast

Reduced expression of metastas ...... r patients with bladder cancer

@en

Reduced expression of metastas ...... r patients with bladder cancer

@nl

P1433

Q28264424-E8266622-C171-4A43-8635-79EC0BAF6F87

P1476

Q28264424-9DD55504-03FD-487D-A88B-486E63DE2767

P2093

Q28264424-3FE835D9-4627-4FD4-8A85-14904B1FE107

Q28264424-6A614E4F-5D6D-4B58-9B9A-007B9974E35A

Q28264424-A7940B65-0C0E-44FD-8578-E3F9420F8C01

Q28264424-B6DBFF48-3C26-4CAA-8448-916D559519F7

Q28264424-B77CCB43-B14E-4D45-9478-F70670A1E381

Q28264424-D49709D6-FB31-4DAC-BE0F-A5FD4B22C121

P304

Q28264424-37F48669-9A07-4E05-A621-0AFC4C9E0E70

P31

Q28264424-DD62D936-6B51-4D37-9A00-91481DB15BB4

P3181

Q28264424-AB4981EC-22C4-4689-83D7-DA679721AA56

P356

Q28264424-38D76ADD-E467-4AFB-A8A3-9575C21A3576

P407

Q28264424-0F055062-765D-4C9A-9D03-F1F0AA6C76BB

P433

Q28264424-3AE9242E-CC21-4111-B1E8-87C07A2E9A29

P478

Q28264424-EC15B768-190A-4155-845D-C99FAB42A809

P577

Q28264424-493D604F-D961-4CB0-9EEF-4E1AFB92D5C4

P698

Q28264424-9EDE90E7-991E-4B23-9A7D-63E13D8D3908

P921

Q28264424-B4D9FA4F-E997-4157-8BA0-C97FB3912C49

P3181

P356

1078-0432.CCR-03-0653

P1433

Clinical Cancer Research

P1476

Reduced expression of metastas ...... r patients with bladder cancer

@en

P2093

Dan Theodorescu

http://www.w3.org/2001/XMLSchema#string

G M Hampton

http://www.w3.org/2001/XMLSchema#string

G Oxford

http://www.w3.org/2001/XMLSchema#string

H F Frierson

http://www.w3.org/2001/XMLSchema#string

L M Sapinoso

http://www.w3.org/2001/XMLSchema#string

M R Conaway

http://www.w3.org/2001/XMLSchema#string

P304

3800-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2143704

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-03-0653

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15173088

http://www.w3.org/2001/XMLSchema#string

P921